GeneDx to Participate in Upcoming Investor Conferences
6 augusti, 14:30
6 augusti, 14:30
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Live and archived webcasts of the presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250806808775/en/
6 augusti, 14:30
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Live and archived webcasts of the presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250806808775/en/
Trumps handelskrig
Analys
Inflationen
Fonder
Aktieråd
Trumps handelskrig
Analys
Inflationen
Fonder
Aktieråd
1 DAG %
Senast
Asmodee
Idag, 07:32
Bättre resultat än väntat för Asmodee
OMX Stockholm 30
1 DAG %
Senast
2 593,76